Financhill
Back

Ginkgo Bioworks Holdings Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
45

DNA
Ginkgo Bioworks Holdings

Last Price:
9.44
Seasonality Move:
-37.29%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

Ginkgo Bioworks Holdings Price Quote

$9.44

Ginkgo Bioworks Holdings Key Stats

Sell
45
Ginkgo Bioworks Holdings (DNA) is a Sell

Day range:
$9.26 - $10.48
52-week range:
$5.26 - $75.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.21
P/B ratio:
0.68%

Volume:
1.5M
Avg. volume:
1.4M
1-year change:
-83.61%
Market cap:
$542.6M
Revenue:
$251.5M
EPS:
$-12.99

How Much Does Ginkgo Bioworks Holdings Make?

Is Ginkgo Bioworks Holdings Growing As A Company?

Ginkgo Bioworks Holdings Stock Price Performance

What Is Ginkgo Bioworks Holdings 52-Week High & Low?

Ginkgo Bioworks Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ginkgo Bioworks Holdings?

Is Ginkgo Bioworks Holdings Cash Flow Positive?

  • What Is DNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$335M
  • What Is Ginkgo Bioworks Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.2M
  • What Is Ginkgo Bioworks Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$95.8M

Ginkgo Bioworks Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    DNA return on invested capital is -65.54%
  • What Is Ginkgo Bioworks Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -38.86%
  • What Is DNA Return On Equity?
    ROE is a measure of profitability and is -65.54%

Ginkgo Bioworks Holdings Earnings Date & Stock Price

Ginkgo Bioworks Holdings Competitors

Ginkgo Bioworks Holdings Dividend Yield

Ginkgo Bioworks Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 59.12% 97.94%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 1
Price Target: 8.20
Downside from Last Price: -13.14%

Major Shareholders

  • How many DNA shares are owned by institutional investors?
    253.7M DNA shares are owned by institutional investors
  • How many DNA shares are owned by insiders?
    34.4M DNA shares are owned by insiders